Agilent Technologies, Inc. - Diagnostics and Genomics SS Tumor Map Assay Probe, RNA, 16, EA
The Agilent SureSelect Tumor Map RNA Probe Kit (16 reactions) is designed for use in targeted RNA sequencing applications, enabling comprehensive profiling of gene expression in tumor samples. This kit utilizes Agilent's SureSelect technology to provide high specificity and sensitivity for the detection of RNA targets, facilitating the identification of gene fusions, alternative splicing events, and expression changes relevant to cancer research. The kit includes all necessary reagents for probe-based enrichment of RNA targets from complex biological samples, supporting robust and reproducible results in translational and clinical research workflows.